Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Cross

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of the Rheumatic Diseases|April 1, 1985
Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritisS M Cross, R A Hazelton
Immunology Today|October 8, 2014
A cell-mediated cause of chronic inflammationS M Cross, R A Hazelton
Cancer Communications|January 1, 1989
Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diesterL D Gorsky, S M Cross, M J Morin
British Journal of Rheumatology|November 1, 1986
A family study of the prevalence of antibodies to the rheumatoid arthritis associated nuclear antigen (RANA)R A Hazelton, S M Cross, G Robert, et al.
The Journal of Infectious Diseases|July 1, 1988
Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virusT B Sculley, S M Cross, P Borrow, et al.
Clinical Science (London, England : 1979)|November 1, 1982
Purine synthesis de novo in lymphocytes from patients with goutR B Gordon, A C Counsilman, S M Cross, et al.
Australian and New Zealand Journal of Medicine|June 1, 1985
A report of three cases of Yersinia reactive arthritisR A Hazelton, G J Seymour, S M Cross, et al.
The Journal of Infectious Diseases|October 23, 1997
Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infectionS L Elliott, S J Pye, C Schmidt, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune diseaseI S Misko, S M Cross, R Khanna, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of the Rheumatic Diseases|April 1, 1985
Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritisS M Cross, R A Hazelton
Immunology Today|October 8, 2014
A cell-mediated cause of chronic inflammationS M Cross, R A Hazelton
Cancer Communications|January 1, 1989
Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diesterL D Gorsky, S M Cross, M J Morin
British Journal of Rheumatology|November 1, 1986
A family study of the prevalence of antibodies to the rheumatoid arthritis associated nuclear antigen (RANA)R A Hazelton, S M Cross, G Robert, et al.
The Journal of Infectious Diseases|July 1, 1988
Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virusT B Sculley, S M Cross, P Borrow, et al.
Clinical Science (London, England : 1979)|November 1, 1982
Purine synthesis de novo in lymphocytes from patients with goutR B Gordon, A C Counsilman, S M Cross, et al.
Australian and New Zealand Journal of Medicine|June 1, 1985
A report of three cases of Yersinia reactive arthritisR A Hazelton, G J Seymour, S M Cross, et al.
The Journal of Infectious Diseases|October 23, 1997
Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infectionS L Elliott, S J Pye, C Schmidt, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune diseaseI S Misko, S M Cross, R Khanna, et al.
Pageof 2